CIK 0000744218 · Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133191702
- Phone
- 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-15 | Martin Samuel Bates SVP and CFO | Option exercise · Incentive Stock Option (Right to Buy) | −3,750 | 28,171 | ||
| 2021-11-12 | Young Diane C. SVP, Chief Medical Officer | Option exercise | +4,600 | $10.38 | $48K | 6,715 |
| 2021-11-12 | Young Diane C. SVP, Chief Medical Officer | Sale | −4,600 | $42.94 | $198K | 2,115 |
| 2021-11-12 | Young Diane C. SVP, Chief Medical Officer | Option exercise · Incentive Stock Option (Right to Buy) | −4,600 | 67,400 | ||
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Option exercise | +5,018 | $9.02 | $45K | 6,793 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Option exercise | +938 | $2.78 | $3K | 7,731 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Sale | −4,302 | $44.11 | $190K | 3,429 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Sale | −901 | $43.06 | $39K | 2,528 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Sale | −2,120 | $41.62 | $88K | 408 |
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Option exercise · Incentive Stock Option (Right to Buy) | −5,018 | 13,315 | ||
| 2021-11-01 | Cavanaugh Sarah SVP of Corp Affairs & Admin. | Option exercise · Incentive Stock Option (Right to Buy) | −938 | 42,062 | ||
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Option exercise | +8,555 | $2.78 | $24K | 9,043 |
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Sale | −2,528 | $44.12 | $112K | 6,515 |
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Sale | −600 | $43.11 | $26K | 5,915 |
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Sale | −1,189 | $41.62 | $49K | 4,726 |
| 2021-11-01 | Crowley Elizabeth Sr. VP &CPDO | Option exercise · Incentive Stock Option (Right to Buy) | −8,555 | 34,445 | ||
| 2021-11-01 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Option exercise | +600 | $2.78 | $2K | 11,847 |
| 2021-11-01 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Sale | −600 | $41.71 | $25K | 11,247 |
| 2021-11-01 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Option exercise · Incentive Stock Option (Right to Buy) | −600 | 42,400 | ||
| 2021-08-11 | Heath-Chiozzi Margo SVP of Regulatory Affairs | Option exercise | +10,000 | $9.02 | $90K | 11,247 |
Page 12 of 17 · 325 trades